Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 3
2004 7
2005 6
2006 6
2007 10
2008 2
2009 4
2010 6
2011 8
2012 8
2013 7
2014 9
2015 11
2016 5
2017 4
2018 10
2019 16
2020 22
2021 26
2022 17
2023 17
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

179 results

Results by year

Filters applied: . Clear all
Page 1
Measuring fatigue: a meta-review.
Machado MO, Kang NC, Tai F, Sambhi RDS, Berk M, Carvalho AF, Chada LP, Merola JF, Piguet V, Alavi A. Machado MO, et al. Among authors: piguet v. Int J Dermatol. 2021 Sep;60(9):1053-1069. doi: 10.1111/ijd.15341. Epub 2020 Dec 10. Int J Dermatol. 2021. PMID: 33301180 Review.
Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations.
Garg A, Malviya N, Strunk A, Wright S, Alavi A, Alhusayen R, Alikhan A, Daveluy SD, Delorme I, Goldfarb N, Gulliver W, Hamzavi I, Jaleel T, Kimball AB, Kirby JS, Kirchhof MG, Lester J, Lev-Tov H, Lowes MA, Micheletti R, Orenstein LA, Piguet V, Sayed C, Tan J, Naik HB. Garg A, et al. Among authors: piguet v. J Am Acad Dermatol. 2022 May;86(5):1092-1101. doi: 10.1016/j.jaad.2021.01.059. Epub 2021 Jan 23. J Am Acad Dermatol. 2022. PMID: 33493574 Free PMC article. Review.
Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trial.
Haberman RH, MacFarlane KA, Catron S, Samuels J, Blank RB, Toprover M, Uddin Z, Hu J, Castillo R, Gong C, Qian K, Piguet V, Tausk F, Yeung J, Neimann AL, Gulliver W, Thiele RG, Merola JF, Ogdie A, Rahman P, Chakravarty SD, Eder L, Ritchlin CT, Scher JU. Haberman RH, et al. Among authors: piguet v. BMJ Open. 2022 Dec 23;12(12):e063650. doi: 10.1136/bmjopen-2022-063650. BMJ Open. 2022. PMID: 36564123 Free PMC article.
Global perspectives for the management of onychomycosis.
Gupta AK, Mays RR, Versteeg SG, Piraccini BM, Takwale A, Shemer A, Babaev M, Grover C, Di Chiacchio NG, Taborda PRO, Taborda VBA, Shear NH, Piguet V, Tosti A. Gupta AK, et al. Among authors: piguet v. Int J Dermatol. 2019 Oct;58(10):1118-1129. doi: 10.1111/ijd.14346. Epub 2018 Dec 25. Int J Dermatol. 2019. PMID: 30585300 Review.
A Paradigm Shift in the Treatment and Management of Onychomycosis.
Gupta AK, Venkataraman M, Renaud HJ, Summerbell R, Shear NH, Piguet V. Gupta AK, et al. Among authors: piguet v. Skin Appendage Disord. 2021 Aug;7(5):351-358. doi: 10.1159/000516112. Epub 2021 May 11. Skin Appendage Disord. 2021. PMID: 34604322 Free PMC article. Review.
Top Ten Research Priorities for Psoriasis, Atopic Dermatitis and Hidradenitis Suppurativa: The SkIN Canada Priority Setting Initiative.
Drucker AM, Kleiner O, Manion R, Philip A, Dutz J, Barnard K, Fradette J, Germain L, Gniadecki R, Litvinov I, Logsetty S, Manolson M, Mydlarski PR, Piguet V, Ward D, Zhou Y, Chan AW; Skin Investigation Network of Canada Priority Setting Collaborative. Drucker AM, et al. Among authors: piguet v. J Cutan Med Surg. 2023 Mar-Apr;27(2):133-139. doi: 10.1177/12034754231156103. Epub 2023 Feb 21. J Cutan Med Surg. 2023. PMID: 36995350 Free PMC article.
179 results